Ferring Pharmaceuticals [clinicaltrials_resource:2d5c6aa533f142db69c3d2bb6f28f821]
affiliation [clinicaltrials_vocabulary:affiliation]
Effectiveness and Safety of Firmagon® [clinicaltrials:NCT00930319]clinicaltrials:NCT01071915Quality of Life With TESTIM® [clinicaltrials:NCT01148433]clinicaltrials:NCT01215513Compliance and Efficacy in the Use of PICOPREP® [clinicaltrials:NCT01220453]clinicaltrials:NCT01225835clinicaltrials:NCT01280981Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP [clinicaltrials:NCT01330771]Assessment of the Therapeutic Utility of hMG-HP [clinicaltrials:NCT01330784]Assessment of the Effectiveness and Tolerability of Ovarian Hyperstimulation [clinicaltrials:NCT01331720]Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist [clinicaltrials:NCT01331733]Adipocyte Function and Somtropin Deficiency [clinicaltrials:NCT01351818]Assessment of the Effectiveness of Menopur in Intrauterine Insemination [clinicaltrials:NCT01354834]User Surveillance in Ulcerative Colitis [clinicaltrials:NCT01363453]Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON [clinicaltrials:NCT01365351]MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis [clinicaltrials:NCT01368913]Mesalazine (PENTASA®) in Ulcerative Colitis [clinicaltrials:NCT01517607]
collaborator [clinicaltrials_vocabulary:collaborator]
clinicaltrials:NCT00038766clinicaltrials:NCT00113568clinicaltrials:NCT00116753clinicaltrials:NCT00116779clinicaltrials:NCT00117286clinicaltrials:NCT00117312clinicaltrials:NCT00117949A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE) [clinicaltrials:NCT00209261]Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis [clinicaltrials:NCT00209287]Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission [clinicaltrials:NCT00209300]A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor [clinicaltrials:NCT00209326]clinicaltrials:NCT00215657clinicaltrials:NCT00215683A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease [clinicaltrials:NCT00225810]Desmopressin Response in the Young [clinicaltrials:NCT00230594]clinicaltrials:NCT00245466A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis [clinicaltrials:NCT00245479]The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease" [clinicaltrials:NCT00245505]An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG [clinicaltrials:NCT00250250]clinicaltrials:NCT00257556clinicaltrials:NCT00268892clinicaltrials:NCT00295750A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH [clinicaltrials:NCT00296465]Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF) [clinicaltrials:NCT00296478]clinicaltrials:NCT00308711Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide [clinicaltrials:NCT00329693]Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour [clinicaltrials:NCT00346840]clinicaltrials:NCT00379236clinicaltrials:NCT00386308clinicaltrials:NCT00401193Double-Blind,Randomized,Placebo-Controlled Efficacy & Safety Study of EUFLEXXA™ for Treatment of OA of the First CMC [clinicaltrials:NCT00423371]clinicaltrials:NCT00434122clinicaltrials:NCT00451958clinicaltrials:NCT00468286Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia [clinicaltrials:NCT00477490]clinicaltrials:NCT00527488Pharmacokinetics and Safety of the 100 Mcg Misoprostol Vaginal Insert (MVI 100) [clinicaltrials:NCT00528255]Effect of Oxytocin and Vasopressin Antagonists on Uterine Contractions [clinicaltrials:NCT00587327]Canadian Active & Maintenance Modified Pentasa Study [clinicaltrials:NCT00603733]An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults [clinicaltrials:NCT00615836]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
organization [clinicaltrials_vocabulary:organization]
clinicaltrials:NCT00038766clinicaltrials:NCT00113568clinicaltrials:NCT00116753clinicaltrials:NCT00116779clinicaltrials:NCT00117286clinicaltrials:NCT00117312clinicaltrials:NCT00117949A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE) [clinicaltrials:NCT00209261]Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis [clinicaltrials:NCT00209287]Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission [clinicaltrials:NCT00209300]A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor [clinicaltrials:NCT00209326]clinicaltrials:NCT00215657clinicaltrials:NCT00215683A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease [clinicaltrials:NCT00225810]Desmopressin Response in the Young [clinicaltrials:NCT00230594]clinicaltrials:NCT00245466A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis [clinicaltrials:NCT00245479]The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease" [clinicaltrials:NCT00245505]An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG [clinicaltrials:NCT00250250]clinicaltrials:NCT00257556clinicaltrials:NCT00268892clinicaltrials:NCT00295750A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH [clinicaltrials:NCT00296465]Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF) [clinicaltrials:NCT00296478]clinicaltrials:NCT00308711Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide [clinicaltrials:NCT00329693]Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour [clinicaltrials:NCT00346840]clinicaltrials:NCT00379236clinicaltrials:NCT00386308clinicaltrials:NCT00401193Double-Blind,Randomized,Placebo-Controlled Efficacy & Safety Study of EUFLEXXA™ for Treatment of OA of the First CMC [clinicaltrials:NCT00423371]clinicaltrials:NCT00434122clinicaltrials:NCT00451958clinicaltrials:NCT00468286Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia [clinicaltrials:NCT00477490]clinicaltrials:NCT00527488Pharmacokinetics and Safety of the 100 Mcg Misoprostol Vaginal Insert (MVI 100) [clinicaltrials:NCT00528255]Effect of Oxytocin and Vasopressin Antagonists on Uterine Contractions [clinicaltrials:NCT00587327]Canadian Active & Maintenance Modified Pentasa Study [clinicaltrials:NCT00603733]An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults [clinicaltrials:NCT00615836]
source [clinicaltrials_vocabulary:source]
Ferring Pharmaceuticals [clinicaltrials_resource:2d5c6aa533f142db69c3d2bb6f28f821]
Bio2RDF identifier
2d5c6aa533f142db69c3d2bb6f28f821
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2d5c6aa533f142db69c3d2bb6f28f821
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:2d5c6aa533f142db69c3d2bb6f28f821
title
Ferring Pharmaceuticals
@en
type
label
Ferring Pharmaceuticals [clinicaltrials_resource:2d5c6aa533f142db69c3d2bb6f28f821]
@en